{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:28:49Z","timestamp":1787668129324,"version":"build-2736575974"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Diabetic retinopathy (DR) remains a leading cause of preventable blindness worldwide. However, current therapies predominantly target downstream vascular pathology and leave upstream drivers largely unaddressed. The emerging gut-retina axis paradigm reframes DR as a systemic disorder intricately linked to intestinal homeostasis. This review provides a comprehensive and updated synthesis of the gut-retina axis in DR, with three distinctive contributions that set it apart from earlier overviews. First, we systematically dissect the differential roles of specific microbial metabolites. We distinguish the opposing effects of primary versus secondary bile acids, the divergent bioactivities of conjugated versus unconjugated forms, and the dual inflammatory and protective functions of short-chain fatty acids. This analysis offers a nuanced mechanistic framework that moves beyond generalized descriptions of dysbiosis. Second, we critically evaluate the methodological heterogeneity that currently impedes cross-study comparability and propose practical standardization strategies to accelerate clinical translation. Third, we present an integrated overview of emerging therapeutic modalities, including next-generation probiotics, metabolite-targeted interventions, fecal microbiota transplantation, and natural product\u2013based nanomedicines, while candidly addressing the translational gap between robust preclinical findings and limited human evidence. Importantly, we highlight how Mendelian randomization studies are beginning to establish causal links between specific gut taxa and DR risk, complementing traditional association-based reports. By integrating multi-omics perspectives, methodological rigor, and therapeutic innovation, this review offers a forward-looking roadmap for transforming gut-retina axis insights into actionable precision medicine strategies for DR.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1868837","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:48:40Z","timestamp":1787665720000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The gut-retina axis in diabetic retinopathy: a new paradigm for pathogenesis and therapeutic intervention"],"prefix":"10.3389","volume":"17","author":[{"given":"Bainan","family":"Tong","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, The Second Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Second Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Second Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Second Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.963615","article-title":"The pathophysiological mechanisms underlying diabetic retinopathy","volume":"10","author":"Wei","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3420187","article-title":"The oxidative stress and mitochondrial dysfunction during the pathogenesis of diabetic retinopathy","volume":"2018","author":"Wu","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1256878","article-title":"Research progress of diabetic retinopathy and gut microecology","volume":"14","author":"Wang","year":"2023","journal-title":"Front Microbiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1205846","article-title":"The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124758","article-title":"Gypenoside A-loaded mPEG-PLGA nanoparticles ameliorate high-glucose-induced retinal microvasculopathy by inhibiting ferroptosis","volume":"666","author":"Chen","year":"2024","journal-title":"Int J Pharm"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2026.121661","article-title":"Chen's Jinshui Pills ameliorate diabetic retinopathy in mice and are associated with intestinal barrier protection and anti-inflammatory effects","volume":"366","author":"Jiang","year":"2026","journal-title":"J Ethnopharmacol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.159618","article-title":"A trackable mitochondria-targeting nanosystem for mitochondrial redox and mitophagy regulation in diabetic retinopathy management","volume":"505","author":"Yao","year":"2025","journal-title":"Chem Eng J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-02022-3","article-title":"Targeting the gut-retina axis: mechanistic insights and therapeutic prospects for diabetic retinopathy","volume":"33","author":"Jiang","year":"2025","journal-title":"Inflammopharmacology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108867","article-title":"The gut microbiota in retinal diseases","volume":"214","author":"Bringer","year":"2022","journal-title":"Exp Eye Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13051101","article-title":"Exploring the gut microbiota-retina axis: implications for health and disease","volume":"13","author":"Schiavone","year":"2025","journal-title":"Microorganisms"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-025-06906-6","article-title":"Early-stage diabetic retinopathy: gut-metabolic triggers, immune-neurodegeneration, and interventions","volume":"263","author":"Niu","year":"2025","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9100905","article-title":"Diabetic retinopathy: the role of mitochondria in the neural retina and microvascular disease","volume":"9","author":"Miller","year":"2020","journal-title":"Antioxidants"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122386","article-title":"The role of Keap1-Nrf2 signaling pathway during the progress and therapy of diabetic retinopathy","volume":"338","author":"Chen","year":"2024","journal-title":"Life Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2023.02.017","article-title":"Microbiome and retinal vascular diseases","volume":"193","author":"Lincke","year":"2023","journal-title":"Am J Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.926926","article-title":"Composition and diversity of gut microbiota in diabetic retinopathy","volume":"13","author":"Bai","year":"2022","journal-title":"Front Microbiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.930318","article-title":"Causal effects of gut microbiota on diabetic retinopathy: a Mendelian randomization study","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/life13040968","article-title":"Gut microbiota dysbiosis in diabetic retinopathy-current knowledge and future therapeutic targets","volume":"13","author":"Serban","year":"2023","journal-title":"Life (Basel)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v14.i6.862","article-title":"Alteration of intestinal microbiota is associated with diabetic retinopathy and its severity: samples collected from southeast coast Chinese","volume":"14","author":"Gu","year":"2023","journal-title":"World J Diabetes"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1604315","article-title":"The role of gut microbiota dysbiosis in the inflammatory pathogenesis of diabetic retinopathy","volume":"16","author":"Xie","year":"2025","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-022-02296-z","article-title":"The role of lipopolysaccharides in diabetic retinopathy","volume":"22","author":"Qin","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03656-y","article-title":"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2025.5643","article-title":"Mechanisms of action of retinal microglia in diabetic retinopathy","volume":"56","author":"Bai","year":"2025","journal-title":"Int J Mol Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12974-018-1373-4","article-title":"Colony-stimulating factor 1 receptor inhibition prevents disruption of the blood-retina barrier during chronic inflammation","volume":"15","author":"Kokona","year":"2018","journal-title":"J Neuroinflamm"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030711","article-title":"Cell surface profiling of retinal Muller glial cells reveals association to immune pathways after LPS stimulation","volume":"10","author":"Lorenz","year":"2021","journal-title":"Cells"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041056","article-title":"Potential interplay between hyperosmolarity and inflammation on retinal pigmented epithelium in pathogenesis of diabetic retinopathy","volume":"19","author":"Willermain","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115569","article-title":"Targeting the NLRP3 inflammasome in diabetic retinopathy: from pathogenesis to therapeutic strategies","volume":"212","author":"Yang","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2174\/1573399814666181017103844","article-title":"Molecular and pathophysiological mechanisms of diabetic retinopathy in relation to adhesion molecules","volume":"15","author":"Joy","year":"2019","journal-title":"Curr Diabetes Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1055087","article-title":"The role of inflammation in immune system of diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications","volume":"13","author":"Yue","year":"2022","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-020-01610-9","article-title":"Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy","volume":"58","author":"Liu","year":"2021","journal-title":"Acta Diabetol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.5935\/0004-2749.2021-0527","article-title":"The role of trimethylamine-N-oxide level in the diagnosis of diabetic retinopathy and the differential diagnosis of diabetic and nondiabetic retinopathy","volume":"87","author":"Yakar","year":"2024","journal-title":"Arq Bras Oftalmol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316155","article-title":"Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial","volume":"68","author":"Heianza","year":"2019","journal-title":"Gut"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00139","article-title":"Gut microbiota-dependent metabolite trimethylamine N-oxide contributes to cardiac dysfunction in Western diet-induced obese mice","volume":"8","author":"Chen","year":"2017","journal-title":"Front Physiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2018.01.007","article-title":"Gut flora-dependent metabolite trimethylamine-N-oxide accelerates endothelial cell senescence and vascular aging through oxidative stress","volume":"116","author":"Ke","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/8224752","article-title":"Trimethylamine-N-oxide promotes high-glucose-induced dysfunction and NLRP3 inflammasome activation in retinal microvascular endothelial cells","volume":"2023","author":"Xue","year":"2023","journal-title":"J Ophthalmol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2025.110399","article-title":"The association of trimethylamine N-oxide with diabetic retinopathy pathology: insights from network toxicology and molecular docking analysis","volume":"256","author":"Gao","year":"2025","journal-title":"Exp Eye Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3389\/fendo.2020.00591","article-title":"Role of Takeda G protein-coupled receptor 5 in microvascular endothelial cell dysfunction in diabetic retinopathy (review)","volume":"24","author":"Zhang","year":"2022","journal-title":"Exp Ther Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.s411522","article-title":"Association of serum bile acid and unsaturated fatty acid profiles with the risk of diabetic retinopathy in type 2 diabetic patients","volume":"16","author":"Feng","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40168-021-01101-1","article-title":"Review: microbial transformations of human bile acids","volume":"9","author":"Guzior","year":"2021","journal-title":"Microbiome"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1530\/eje-20-1101","article-title":"Metabolic impact of bile acids in gestation","volume":"184","author":"Fan","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41419-023-06111-5","article-title":"TGR5 supresses cGAS\/STING pathway by inhibiting GRP75-mediated endoplasmic reticulum-mitochondrial coupling in diabetic retinopathy","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/biom11050626","article-title":"Glycine-conjugated bile acids protect RPE tight junctions against oxidative stress and inhibit choroidal endothelial cell angiogenesis in vitro","volume":"11","author":"Warden","year":"2021","journal-title":"Biomolecules"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/cells12141888","article-title":"Bile acids, intestinal barrier dysfunction, and related diseases","volume":"12","author":"Shi","year":"2023","journal-title":"Cells"},{"key":"B43","doi-asserted-by":"publisher","first-page":"9250763","DOI":"10.26599\/FSHW.2025.9250763","article-title":"A synbiotic-like combination of highland barley \u03b2-glucan and Parabacteroides distasonis modulates diabetic retinopathy through gut-retina axis","author":"Ma","year":"2025","journal-title":"Food Sci Hum Wellness"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40662-023-00362-1","article-title":"Homocysteine and mitochondrial quality control in diabetic retinopathy","volume":"11","author":"Malaviya","year":"2024","journal-title":"Eye Vis (Lond)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062470","article-title":"Short-chain fatty acids and the gut-retina connection: a systematic review","volume":"26","author":"Ciurariu","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.66.6.23","article-title":"Short-chain fatty acids are potential biomarkers of immune regulation in diabetic retinopathy","volume":"66","author":"Qin","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12967-023-04259-4","article-title":"Sodium butyrate ameliorates diabetic retinopathy in mice via the regulation of gut microbiota and related short-chain fatty acids","volume":"21","author":"Huang","year":"2023","journal-title":"J Transl Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15970","article-title":"Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: a promising therapy","volume":"37","author":"Peng","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122744","article-title":"Gut dysbiosis contributes to SCFAs reduction-associated adipose tissue macrophage polarization in gestational diabetes mellitus","volume":"350","author":"Li","year":"2024","journal-title":"Life Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123999","article-title":"Diabetic kidney disease and aging: focus on gut microbiota","volume":"381","author":"Rong","year":"2025","journal-title":"Life Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23136939","article-title":"Pharmacological effects of polyphenol phytochemicals on the intestinal inflammation via targeting TLR4\/NF-\u03baB signaling pathway","volume":"23","author":"Yu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12017-025-08883-9","article-title":"The role of gut microbiota in modulating immune signaling pathways in autoimmune diseases","volume":"27","author":"Younis","year":"2025","journal-title":"Neuromolecular Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/toxres\/tfaf105","article-title":"Albiflorin improves diabetic retinopathy by mitigating oxidative stress and inflammation via the TLR-4\/NF-kB signaling pathway","volume":"14","author":"Xie","year":"2025","journal-title":"Toxicol Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119567","article-title":"Asiatic acid attenuates diabetic retinopathy through TLR4\/MyD88\/NF-\u03baB p65 mediated modulation of microglia polarization","volume":"277","author":"Fang","year":"2021","journal-title":"Life Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12079-022-00695-x","article-title":"Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: focus on the available therapeutic approaches and gut microbiome","volume":"17","author":"Shahini","year":"2023","journal-title":"J Cell Commun Signal"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109145","article-title":"Microglia-endothelial cross-talk regulates diabetesinduced retinal vascular dysfunction through remodeling inflammatory microenvironment","volume":"27","author":"Ben","year":"2024","journal-title":"Iscience"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073148","article-title":"Oxidative stress, gut microbiota, and extracellular vesicles: interconnected pathways and therapeutic potentials","volume":"26","author":"Ma","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.108970","article-title":"The STING pathway: an uncharacterized angle beneath the gut-retina axis","volume":"217","author":"Qin","year":"2022","journal-title":"Exp Eye Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70442","article-title":"Oral 7,8-dihydroxyflavone protects retinal ganglion cells by modulating the gut-retina axis and inhibiting ferroptosis via the indoleacrylic acid-AhR-ALDH1A3-FSP1 pathway","volume":"31","author":"Zhou","year":"2025","journal-title":"CNS Neurosci Ther"},{"key":"B60","doi-asserted-by":"publisher","first-page":"105690","DOI":"10.1016\/j.jff.2023.105690","article-title":"Long-term ingestion of \u03b2-lactoglobulin-bound AGEs induces colonic inflammation by modulating RAGE (TLR4)\/MYD88\/NF-\u03baB signaling pathway and gut microbiota in mice","volume":"107","author":"Shi","year":"2023","journal-title":"J Funct Foods"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2023.108456","article-title":"Efficacy and safety of sodium glucose cotransporter 2 inhibitors plus standard care in diabetic kidney disease: a systematic review and meta-analysis","volume":"37","author":"Woodhams","year":"2023","journal-title":"J Diabetes Complications"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115881","article-title":"Discussing pathologic mechanisms of diabetic retinopathy & therapeutic potentials of curcumin and \u03b2-glucogallin in the management of diabetic retinopathy","volume":"169","author":"Rohilla","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.10.048","article-title":"Pomegranate peel extract alleviates diabetic retinopathy by suppressing the PI3K\/AKT\/HIF-1alpha\/VEGF pathway and gut microbiota modulation","volume":"10","author":"Ren","year":"2025","journal-title":"J Adv Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118800","article-title":"Gut-eye axis in ophthalmic diseases: focus on ocular neurodegeneration","volume":"193","author":"Zhou","year":"2025","journal-title":"BioMed Pharmacother"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2024.109860","article-title":"Drp1-dependent mitochondrial fragmentation mediates photoreceptor abnormalities in type 1 diabetic retina","volume":"242","author":"Tang","year":"2024","journal-title":"Exp Eye Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2022.07.008","article-title":"Role of inflammatory cells in pathophysiology and management of diabetic retinopathy","volume":"67","author":"Kovoor","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s40123-020-00278-2","article-title":"The gut-eye axis: lessons learned from murine models","volume":"9","author":"Floyd","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/biology14030275","article-title":"The role of Th17\/Treg axis in retinal pathology associated with diabetes and treatment options","volume":"14","author":"Mickael","year":"2025","journal-title":"Biol (Basel)"},{"key":"B69","doi-asserted-by":"publisher","first-page":"667632","DOI":"10.21203\/rs.3.rs-131500\/v1","article-title":"Alterations of the gut microbiome and metabolome in patients with proliferative diabetic retinopathy","volume":"12","author":"Ye","year":"2021","journal-title":"Front Microbiol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.943325","article-title":"Metagenomic shotgun sequencing and metabolomic profiling identify specific human gut microbiota associated with diabetic retinopathy in patients with type 2 diabetes","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13091007","article-title":"Recent advances and perspectives in relation to the metabolomics-based study of diabetic retinopathy","volume":"13","author":"He","year":"2023","journal-title":"Metabolites"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114994","article-title":"Gut microbiota and metabolites in diabetic retinopathy: insights into pathogenesis for novel therapeutic strategies","volume":"164","author":"Cai","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4547878","article-title":"Ethanolamine as a biomarker and biomarker-based therapy for diabetic retinopathy in glucose-well-controlled diabetic patients","volume":"69","author":"Hu","year":"2024","journal-title":"Sci Bull"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122483","article-title":"The mechanism of EGFL7 regulating neovascularization in diabetic retinopathy through the PI3K\/AKT\/VEGFA pathway","volume":"340","author":"Xian","year":"2024","journal-title":"Life Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v17.i3.114603","article-title":"Beyond glycemia: the influence of systemic inflammation, lipids, and the gut-retina axis in diabetic retinopathy","volume":"17","author":"Zeppieri","year":"2026","journal-title":"World J Diabetes"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.01.018","article-title":"Regulatory considerations for fecal microbiota transplantation products","volume":"27","author":"Carlson","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10815-024-03292-6","article-title":"Methodological approaches in 16S sequencing of female reproductive tract in fertility patients: a review","volume":"42","author":"Davidson","year":"2025","journal-title":"J Assist Reprod Genet"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1155\/joph\/4233490","article-title":"Causal effects of gut microbiota and associated metabolites on retinal diseases and visual impairment: a Mendelian randomization study","volume":"2026","author":"Yu","year":"2026","journal-title":"J Ophthalmol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202600264r","article-title":"Gut microbiota-derived propionate: a potential therapeutic target for diabetic retinopathy via regulating the gut-retina axis","volume":"40","author":"Gao","year":"2026","journal-title":"FASEB J"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/sim.70394","article-title":"Mendelian randomization methods for causal inference: estimands, identification and inference","volume":"45","author":"Yao","year":"2026","journal-title":"Stat Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1382777","article-title":"Mendelian randomization study and mediation analysis about the relation of inflammatory bowel disease and diabetic retinopathy: the further exploration of gut-retina axis","volume":"15","author":"Lin","year":"2024","journal-title":"Front Endocrinol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10654-025-01324-8","article-title":"Integration of latent factor analysis into multivariable Mendelian randomization","author":"Zhang","year":"2026","journal-title":"Eur J Epidemiol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1359949","article-title":"Postbiotics: emerging therapeutic approach in diabetic retinopathy","volume":"15","author":"Chen","year":"2024","journal-title":"Front Microbiol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1681943","article-title":"Bifidobacterium animalis subsp. lactis BB-12 attenuates diabetic retinopathy through gut microbiota modulation: evidence for the gut-retinal axis","volume":"15","author":"Lin","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-024-01399-2","article-title":"The effects of probiotics supplements on metabolic indices and clinical signs in patients with diabetic retinopathy, a randomized double blind clinical trial","volume":"23","author":"Farajipour","year":"2024","journal-title":"J Diabetes Metab Disord"},{"key":"B86","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41540-025-00607-w","article-title":"Systems biology and microbiome innovations for personalized diabetic retinopathy management","volume":"11","author":"Aminian-Dehkordi","year":"2025","journal-title":"NPJ Syst Biol Appl"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/nu14010166","article-title":"Gut microbiota and complications of type-2 diabetes","volume":"14","author":"Iatcu","year":"2022","journal-title":"Nutrients"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2020.103993","article-title":"HMOs modulate immunoregulation and gut microbiota in a \u03b2-lactoglobulin-induced allergic mice model","volume":"70","author":"Liu","year":"2020","journal-title":"J Funct Foods"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27104527","article-title":"Current understanding of probiotic strains and immune function: from gut microbiota to systemic immunity","volume":"27","author":"Szota","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/jsfa.13370","article-title":"Modulation of gut-microbiota through probiotics and dietary interventions to improve host health","volume":"104","author":"Dasriya","year":"2024","journal-title":"J Sci Food Agric"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2021.108897","article-title":"Visualization of dietary docosahexaenoic acid in whole-body zebrafish using matrix-assisted laser desorption\/ionization mass spectrometry imaging","volume":"100","author":"Yoshinaga","year":"2022","journal-title":"J Nutr Biochem"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103034","article-title":"The role of faecal microbiota transplantation in chronic noncommunicable disorders","volume":"141","author":"Mullish","year":"2023","journal-title":"J Autoimmun"},{"key":"B93","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s40168-024-01833-w","article-title":"Fecal microbiota transplantation alters gut phage communities in a clinical trial for obesity","volume":"12","author":"Zuppi","year":"2024","journal-title":"Microbiome"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1286429","article-title":"The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Microbiol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.infpip.2020.100069","article-title":"Regulation, risk and safety of faecal microbiota transplant","volume":"2","author":"Merrick","year":"2020","journal-title":"Infect Prev Pract"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaf156","article-title":"Fecal microbiota therapy: clinical laboratory testing and metabolomic approaches for donor screening, product assessment, and patient monitoring","volume":"72","author":"Drew","year":"2026","journal-title":"Clin Chem"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/diseases8020009","article-title":"From donor to patient: collection, preparation and cryopreservation of fecal samples for fecal microbiota transplantation","volume":"8","author":"Nicco","year":"2020","journal-title":"Diseases"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2025.124059","article-title":"Structural characterization and protective effects of a glucuronogalactomannan from Tetrastigma hemsleyanum against diabetic retinopathy via targeting ferroptosis pathway","volume":"366","author":"Zhou","year":"2025","journal-title":"Carbohydr Polym"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118963","article-title":"Therapeutic effects of Mudan granules on diabetic retinopathy: mitigating fibrogenesis caused by FBN2 deficiency and inflammation associated with TNF-\u03b1 elevation","volume":"337","author":"Long","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12951-025-03976-w","article-title":"Microglia-specific interleukin-4 delivery by engineered extracellular vesicles restores inner blood-retinal barrier in diabetic retinopathy via GAS6-MERTK pathway","volume":"24","author":"Fan","year":"2025","journal-title":"J Nanobiotechnology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1868837\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:48:42Z","timestamp":1787665722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1868837\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":100,"alternative-id":["10.3389\/fimmu.2026.1868837"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1868837","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1868837"}}